Biogen Idec to add 100 jobs in North Carolina as revenues grow; Pharmacyclics' Imbruvica wins another indication; BMS and J&J get HIV drug approvals;

@FiercePharma: European regulators chart record year for new animal health products. More | Follow @FiercePharma

@EricPFierce: GSK is moving forward with its new API plant in Scotland. Story | Follow @EricPFierce

> Biotech Biogen Idec ($BIIB), which reported a 40% jump in 2014 revenues Thursday to $9.7 billion, intends to add about 100 employees to the 1,300 it already has at its facility in Research Triangle Park, NC. Story

> The U.S. Food and Drug Administration Thursday expanded the use of Pharmacyclics ($PCYC) cancer fighter Imbruvica to include people with Waldenström's macroglobulinemia (WM), a rare form of cancer that begins in the body's immune system. Release

> Sanofi-Synthelabo India has bought a 20% stake in a chain of diabetes clinics in India for 90 crore ($14.5 million). Report

> Abbott Laboratories' ($ABT) CEO Miles White says his company is better protected than some from the foreign exchange effects of a stronger dollar, projecting it will reduce sales by about 6% this year. Story

> The FDA on Thursday approved fixed-dose HIV meds from Johnson & Johnson ($JNJ) and Bristol-Myers Squibb ($BMY), both in combination with a boosting agent made by Gilead Sciences ($GILD). Story

> German Merck ($MRK) today announced that it had named Andreas Stickler, 43 Head of Controlling of the Healthcare Business Sector. Release

Medical Device News

@FierceMedDev: Stomach-draining obesity startup gets $12M in debt to support PMA in mid-2015. More | Follow @FierceMedDev

@EmilyWFierce: Roche and Qualcomm join forces for next-gen remote patient monitoring system. Story | Follow @EmilyWFierce

> Wall Street buys into third med tech IPO of the week: Avinger. More

> J&J to distribute Insuline diabetes device in Russia to stem flagging diabetes care sales. News

> China medical device market to top Japan to claim No. 2 spot globally. Report

Biotech News

@FierceBiotech: Obama wants $215M to kick off 'precision medicine' project. More | Follow @FierceBiotech

@JohnCFierce: $ICPT up 38% this a.m., which is nuts. Article | Follow @JohnCFierce

@DamianFierce: The to-my-knowledge guest list for tomorrow's White House precision medicine thing: $FMI, $VRTX, $MRK, $REGN. | Follow @DamianFierce

> Obama wants $215M to kick off 'precision medicine' project. Story

> Pfizer bails on a $70M rare disease deal with Repligen. More

> Spark nails a $161M IPO to fund its 'breakthrough' gene therapy. News

And Finally... Vivus ($VVUS) Friday announced that the European Commission approved its erectile dysfunction drug Spedra as the first ED treatment that can be effective 15 to 30 minutes before sexual activity. Release